UnoVins, a South Korea–based digital healthcare company, announced on the 12th that it achieved tangible results in expanding its sales channels in North America after participating in CES 2026, held in Las Vegas, the United States, from January 6 to 9 (local time). An UnoVins representative said, ‘Through CES 2026, we have already moved forward with several purchase agreements with global buyers, including those from Mexico and the United States, proving our competitiveness in the global market,’ adding, ‘We will use this momentum to further accelerate our expansion into international markets.’

Founded in October 2024, UnoVins develops and sells digital healthcare solutions. Its flagship products include ‘UNO BrainBody’, a medical-grade kiosk that simultaneously measures ‘electroencephalogram (EEG)’ and ‘photoplethysmography (PPG)’ signals, and ‘UNO CARE’, which measures biometric signals by capturing facial video using a smartphone camera.

UNO BrainBody has obtained ‘Good Manufacturing Practice (GMP)’ certification for medical device manufacturing and quality management, and is currently installed and in operation in approximately 200 locations across a wide range of settings, including clinics and hospitals, public institutions, and corporate welfare centers. UNO CARE is proceeding with manufacturing certification for its portable PPG analysis software, based on UnoVins’ licensed status as a digital medical device manufacturer. Both products have also received CES Innovation Awards.

UnoVins previously participated in ‘MEDICA 2025’, the world’s largest medical device trade fair held in Düsseldorf, Germany, last November. At the event, the company secured meaningful outcomes, including purchase agreements with buyers from Germany, China, Saudi Arabia, and South Africa.